For updates on our latest news, subscribe to our quarterly newsletter.
International Narcotics Control Board releases new report on Availability of Internationally Controlled Drugs
Friday 12 February 2016
by
Suzanne Zhou
Fight for plain truth far from over
Wednesday 6 May 2015
by
Jonathan Liberman
Jonathan Liberman, Director of the McCabe Centre for Law and Cancer, outlines the research findings but says the fight against tobacco companies is far from over - for Australia still but also for other countries, particularly those who are less resourced but vulnerable to the social and health costs of tobacco in coming decades.
Promise of Progress in the Pacific
Tuesday 11 November 2014
by
Alexandra Jones and Ebil Matsutaro
Pacific Island Countries and Territories (PICTs) bear the heaviest burden of non-communicable diseases (NCDs) globally, but there are promising signs that the region is also beginning to develop specific, multi-sectoral responses.
The Doha Declaration: for prevention as well as cure
Wednesday 8 October 2014
by
Suzanne Zhou
The relationship between health and trade is an increasingly prominent item on the global noncommunicable diseases (NCDs) agenda. Although adopted in the context of access to HIV/AIDS, tuberculosis, and malaria medicines, the Doha Declaration covers public health concerns more broadly. The Doha Declaration also applies to NCD prevention measures concerning intellectual property such as certain tobacco control laws.
Building legal capacity into an accelerated global NCD response
Wednesday 20 August 2014
by
Alexandra Jones
Adoption of the Political Declaration on Prevention and Control of Non-communicable Diseases in 2011 represented landmark acknowledgement of non-communicable diseases (NCDs) as a major challenge for development in the 21st Century. Nearly three years later, outcomes of a recent United Nations review highlight the critical need to match ongoing global political commitment with strengthened capacity, including legal capacity, in accelerating a ‘whole-of-government’ and ‘whole-of-society’ response.
The WHO Framework Convention on Tobacco Control at 10: its power for global health and development in the 21st century
Wednesday 6 August 2014
by
Jonathan Liberman
In a guest blog for Edward Elgar, Jonathan Liberman explains that the WHO Framework Convention on Tobacco Control (WHO FCTC) carries great legal and political power for global health and development in the 21st century. Jonathan’s blog draws on his chapter The Power of the WHO FCTC: Understanding its Legal Status and Weight in the new book The Global Tobacco Epidemic and the Law.
A global convention on healthy diets? Some lessons from the WHO Framework Convention on Tobacco Control
Thursday 22 May 2014
by
Jonathan Liberman
Responding to the tobacco industry's claims that plain packaging breaches international trade and investment law
Tuesday 20 May 2014
by
Mark Davison, Jonathan Liberman, and Andrew Mitchell
Last week, McCabe Centre Director Jonathan Liberman and Professors Mark Davison and Andrew Mitchell appeared before the Health Committee of the New Zealand Parliament, which is examining a Bill that would require tobacco products in New Zealand to be sold in plain packaging. They set out why they believe the Bill would not breach New Zealand’s obligations under WTO or international investment law. In this blog, they address some of the claims made by the tobacco industry in its submissions to the Committee.
Eating the Elephant in the Room
Wednesday 26 March 2014
by
Ebil Matsutaro
As a participant in the McCabe Centre Intensive Legal Training Programme during February and March, I learned about important and pressing issues related to tobacco control, alcohol control, obesity, treatment and support for cancer, access to medicines, global action on NCDs, and international trade and investment.
Ad bans, labelling and taxes: exploring the intersection of law and public health in global efforts to prevent obesity
Wednesday 30 October 2013
by
Alexandra Jones and Laura Perriam
What are the bases for developing and implementing laws for obesity prevention? Which levels of government are responsible? What is the role for public health evidence? And how can public health advocates respond to the efforts of opponents of legal approaches who simultaneously overplay gaps in evidence, the limits of legal authority, and technical barriers, with a view to delaying or stalling the use of law?
WTO dispute settlement as a training exercise?
Monday 14 October 2013
by
Jonathan Liberman
Simon Lacey, a Jakarta-based international trade-law practitioner, writes in the Jakarta Globe that he advised Indonesia to challenge Australia's plain packaging legislation in the WTO because it would be a good opportunity to build Indonesia's WTO dispute settlement experience - particularly because the tobacco industry would be footing the bill. We comment on Lacey's perspective and on his judgment that Australia's plain packaging is ‘almost certainly ... an act of regulatory over-reach' and ‘a silly political calculation'.
Waiting out the legal challenges to plain packaging - playing into the tobacco industry's hands?
Friday 4 October 2013
by
Jonathan Liberman
Nearly two years after the passage of Australia's plain packaging legislation, and ten months after it came fully into effect, the international legal challenges continue. Slowly. And the tobacco industry, which is directly pursuing one of the challenges and providing support to the others, is telling governments considering stronger tobacco control measures to wait until the challenges are resolved.
From Australia to Thailand - defending tobacco packaging laws against multinational tobacco industry lawsuits
Friday 27 September 2013
by
Jonathan Liberman
I had the great privilege of being in Bangkok, Thailand, last week to talk with public health and legal colleagues about Thailand's defence of lawsuits brought against it by the multinational tobacco industry.
Cancer Voices Australia v Myriad Genetics Inc: Reflections on a Patent Controversy
Wednesday 11 September 2013
by
Tarishi Desai
Should human cancer disposing genes be considered patentable inventions? What exactly is an ‘invention'? What impact would this have on patient healthcare and cancer research? How does Australia's patent law system operate? These were some of the questions I had to consider when analysing the Federal Court of Australia's historic ruling on the practice of ‘gene patenting' in
Cancer Voices Australia v Myriad Genetics Inc during my internship with the McCabe Centre for Law and Cancer, undertaken earlier this year in partnership with the Melbourne Law School.
Making the law work better for people affected by cancer: employment
Wednesday 4 September 2013
by
Deborah Lawson and Sondra Davoren
While many employers are supportive when an employee is affected by cancer, retaining, returning to, or finding new employment can be difficult for some people who have or have had cancer.
Total
199
articles in this section.